Collegium Pharma (COLL) Says Ciaffoni Will succeed Heffernan as CEO
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced that Joseph Ciaffoni, Executive Vice President and Chief Operating Officer at Collegium will ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)